The Division of Pediatric Hematology/Oncology has been actively engaged in childhood cancer research and treatment for several decades. Since 1998, the Masonic Cancer Center (MCC) at the UMN has been an NCI-Designated Comprehensive Cancer Center. In 2008, the MCC formalized existing cross-departmental collaborations and partnerships through the creation of a Brain Tumor Program Translational Working Group. Translational Working Groups within the MCC are a mechanism to foster interprogrammatic and translational research to promote new discoveries in specific cancers, one of the primary foci being childhood brain tumors. The Brain Tumor Program, which is led by the Department of Pediatrics, accelerates the flow of information from basic science to the discovery of safer and more effective therapies for central nervous system (CNS) tumors. In total, 47 researchers, whose research spans the continuum of scientific research, are a part of the Brain Tumor Program. Given the excellent support of the MCC, these researchers are translating pre-clinical findings into clinical trials conducted here and at other institutions.
*University of Minnesota participates in a limited number of PNOC’s clinical trials.